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Background/aim: The aim of the study is to identify predictors of treatment success with combined transforaminal epidural steroid
injection (TFESI) and dorsal root ganglion pulsed radiofrequency (DRG-PRF) in patients with lumbar radicular pain (LRP) associated
with lumbar disc herniation.
Materials and methods: The study included 48 patients with herniation-related LRP who underwent TFESI and DRG-PRF treatment
between November 1, 2020 and April 30, 2021. Patient age, sex, symptom duration, history of lumbar surgery, and numeric rating scale
(NRS) pain scores before and at 10 days, 1 month, and 3 months after treatment were evaluated retrospectively. Treatment success was
defined as ≥50% improvement or a 4-point decrease in NRS score at 3 months.
Results: Twenty-nine female and 19 male patients with a mean age of 51.54 ± 13.31 years were analyzed. The median symptom duration
was 6 (interquartile range: 8.50) months. Symptom duration did not affect treatment success (p = 0.105). History of spinal surgery was
more common among patients with failed treatment but was not statistically associated with treatment success. A 1-unit increase in
pre-treatment NRS score was associated with 72% lower odds of treatment success (p = 0.022), while a 1-unit increase in NRS score
on post-treatment day 10 compared to the pre-treatment value was associated with 95% lower odds of treatment success (p = 0.008).
Conclusion: Symptom duration and history of spinal surgery were not predictive of treatment success with combined TFESI and DRGPRF for herniation-related LRP. However, the 3-month prognosis was significantly better for patients with a marked reduction in NRS
score at 10 days.
Key words: Transforaminal epidural steroid injection, dorsal root ganglion, pulsed radiofrequency treatment, lumbar radicular pain,
numeric rating scale

1. Introduction
Lumbar radicular pain (LRP) can occur as a result of
mechanical compression of the dorsal root or ganglion
by herniated disc material or due to inflammation caused
by chemokines and enzymes in the disc [1]. Studies have
shown that transforaminal epidural steroid injections
(TFESI) and dorsal root ganglion pulsed radiofrequency
(DRG-PRF) interventions are effective when conservative
treatment methods (e.g., oral analgesic drugs, exercise,
and physiotherapy) are insufficient [2,3].
For LRP secondary to lumbar disc herniation (LDH),
there are reports indicating the short-term efficacy of
TFESI and DRG-PRF interventions when performed
separately [3,4]. In addition, there are also studies
demonstrating the efficacy of applying TFESI and DRGPRF simultaneously [2,5]. Despite evidence that these

methods are effective, successful treatment results are not
obtained in all patients. Several studies have investigated
the potential relationship between clinical parameters
and the results of TFESI and DRG-PRF when used
separately. Different results regarding age and symptom
duration were reported in the studies examining the
effect of clinical features on the success of TFESI [6,7],
while age and history of failed lumbar surgery were
reported to be factors affecting the success of DRG-PRF
therapy [8,9].
A literature search yielded no study investigating
clinical factors affecting treatment success with combined
TFESI and DRG-PRF therapy for LRP. The aim of this
study was to investigate the clinical factors associated
with treatment success after combined TFESI and DRGPRF therapy in patients with LRP due to LDH.
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2. Materials and methods
2.1. Study design
This was a retrospective study.
2.2. Setting
Ethics committee approval for this study was obtained
from the Clinical Research Ethics Committee of Bursa
City Hospital (date: 02.06.2021, decision number: 202110/12). The study included patients who had LDH and
associated chronic radicular pain that did not respond
to conservative treatment consisting of medication and/
or physical therapy and underwent combined TFESI
and DRG-PRF between November 1, 2020 and April
30, 2021 after examination and imaging by the algology
department. Patients whose symptom duration, surgical
history, or numeric rating scale (NRS) pain scores were
not recorded were excluded from the study.
2.3. Lumbar radicular pain clinical assessment and
follow-up protocol
The protocol for combined TFESI and DRG-PRF in our
clinic specifies that this intervention is performed at the
vertebral level(s) causing symptoms in patients meeting
the following criteria:
•
Insufficient analgesia despite the use of at least
one conservative treatment method,
•
LRP persisting for at least 3 months,
•
NRS value of 6 or higher at initial evaluation,
•
Lumbar magnetic resonance imaging (MRI)
demonstrating disc herniation without sequestration at a
level consistent with physical examination findings.

At the patient’s first examination, a detailed history
including symptom duration and history of previous
lumbar surgery is recorded. Patients are asked to rate their
pain intensity using the NRS before the procedure and at 10
days, 1 month, and 3 months after the procedure. Patients
are also asked not to change their previously prescribed
medications for at least 1 month after the procedure.
2.4. Procedures
All patients were evaluated by a single algologist and all
TFESI and DRG-PRF procedures were performed by the
same physician (G.T.). The procedures are performed
under sterile conditions and mild sedation with standard
monitoring. The patient is placed in prone position with
a pillow under the lower abdomen to provide easy access
to the intervertebral foramen. Under anterior-posterior
(AP) fluoroscopy, the C-arm is moved cranially or
caudally to the lower endplate of the vertebra at the target
level. The C-arm is adjusted to a 25–30 degree ipsilateral
oblique angle and skin infiltration with 1 cc 2% lidocaine
is administered. A 10-cm 22-gauge RF needle with 10mm active tip (TOP, Japan) is advanced as far medial to
the intervertebral foramen and near the DRG as possible
using a tunnel vision technique. The needle is positioned
so as not to pass the middle of the intervertebral foramen
in the lateral view and the middle of the pedicle column in
AP and lateral view (Figure 1). After properly positioning
the RF needle, a radiofrequency device (TOP-TLG 10
STP) is used to ensure the impedance readings in the
PRF generator are <400 ohms. With sensory stimulation

Figure 1. Position of the needle in AP and lateral view during DRG PRF.
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applied at 50 Hz, paresthesia is expected in the area
corresponding to the distribution of the patient’s LRP at a
voltage of <0.6 V. After applying 2 Hz motor stimulation,
a confirmatory motor response is sought at 1.5 times the
sensory threshold [2, 5]. After obtaining the appropriate
responses, PRF is performed at 45 V and 42 °C for 120 s.
After the DRG-PRF procedure, the needle is withdrawn
by 2–3 mm to reposition the tip in the safe triangle.
Contrast agent (Omnipaque 300, GE Healthcare, Ireland)
is injected to confirm epidural spread, then a solution of 4
mg dexamethasone in 4 cc saline is administered in each
target level (Figure 2).
2.5 Assessment
After 3 months, ≥ 50% improvement or a 4-point decrease
in NRS score was considered a successful outcome. The
need for alternative treatment and additional analgesic
therapy in the first month of follow-up was regarded as
nonresponse (treatment failure) [2].
3. Statistical analysis
In the present study, posthoc power analysis was performed
based on NRS scores at 3 months after treatment. The mean
NRS score was 5.63 ± 1.45 for patients whose treatment
was unsuccessful (n = 16) and 2.09 ± 0.82 in those whose
treatment was successful (n = 32). The effect size was
calculated as d = 3.01. With this effect size, the power of
the study at an alpha error level of 0.05 was determined
as >95%. Power analysis calculations were made using the
G*Power program (Faul, F., Erdfelder, E., Lang, A.-G., &

Buchner, A. (2007). G*Power 3: A flexible statistical power
analysis program for the social, behavioral, and biomedical
sciences. Behavior Research Methods, 39, 175-191.)
Shapiro–Wilk test was used to evaluate whether
age, symptom duration, and NRS score showed normal
distribution. Based on the results, age was presented as
mean and standard deviation, while symptom duration
and NRS scores were expressed as median and interquartile
range. Independent samples t-test was used to compare
age, and Mann–Whitney U test was used to compare
symptom duration and NRS values between patients with
treatment success and failure. Comparisons of categorical
variables between patient subgroups were performed with
Fisher–Freeman–Halton and chi-square tests. Statistical
analyses were performed using IBM SPSS Statistics version
21.0 for Windows (IBM Corporation, Armonk, NY, USA).
Type I error level was accepted as 5% for all analyses.
Logistic regression analysis was used to identify factors
associated with treatment success. The variables in Table
1 were first evaluated using univariate logistic regression
analysis, and those with p < 0.25 were included in the
multivariate logistic regression model.
4. Results
A total of 55 patients underwent the combined TFESI and
DRG-PRF procedure due to LRP in the 5-month study
period. Of these, 7 patients were excluded from the study
because NRS values were not available for the 3-month followup period. The study group included 29 women and 19 men
with a mean age of 51.54 ± 13.31 years. The mean duration

Figure 2. Position of the needle in AP and lateral view during TFESI.

1243

GAZİOĞLU TÜRKYILMAZ / Turk J Med Sci
of symptoms before injection was 6 months. Injections were
most frequently applied at the level of L5-S1 (47.9%) and
on the left (56.3%) side. The proportion of patients with no
history of previous spinal surgery was 64.6%.
Based on NRS scores, a successful result was obtained in
66.6% of the patients (n = 32). The demographic characteristics
and treatment details of patients with successful and
unsuccessful treatment outcomes are shown in Table 1.
There was no significant difference in age, sex, symptom
duration, injection level and side, and pretreatment NRS
scores between patients with successful and failed TFESI
and DRG-PRF therapy (p > 0.05). However, there was a
significant difference between patients with treatment

success and failure in terms of spinal surgery history (p
< 0.001). Subgroup analyses revealed that the treatment
success rate was higher in patients with no history of spinal
surgery compared to the patients with one or more spinal
surgeries (p < 0.05). A greater decrease in NRS at 10 days,
1 month, and 3 months after treatment compared to the
pre-treatment NRS value was observed in patients whose
treatment was successful (p < 0.001 for all) (Figure 3).
Multivariate logistic regression analysis was performed
including symptom duration, history of spinal surgery,
pretreatment NRS, and change in NRS on posttreatment
day 10 compared to pretreatment values. The results of the
analysis are presented in Table 2.

Table 1. Comparison of demographic characteristics, treatment details, and follow-up data between patients with successful and
unsuccessful treatment.
Treatment outcome

p value

Successful (n = 32)

Unsuccessful (n = 16)

51.72 ± 13.83

51.19 ± 12.63

Female

20 (62.50%)

9 (56.30%)

Male

12 (37.50%)

7 (43.80)

Symptom duration (months)

6 (8.50)

8.50 (18.75)

L4-5

15 (46.90%)

3 (18.80%)

L5-S1

14 (43.80%)

9 (56.30%)

L4-5 and L5-S1

1 (3.10%)

3 (18.80%)

L5-S1 and S1 foramen

2 (6.30%)

1 (6.30%)

Right

8 (25%)

5 (31.30%)

Left

18 (56.30%)

9 (56.30%)

Bilateral

6 (18.80%)

2 (12.50%)

None

27 (87.10%)

4 (12.90%)

Once

4 (33.30%)

8 (66.70%)

Twice or more

1 (20%)

4 (80%)

Pretreatment

6 (0)

6 (1.75)

0.207

Posttreatment day 10

1.50 (1)

4 (3)

-

Posttreatment 1 month

2 (1.50)

5.50 (2)

-

Posttreatment 3 months

2 (0.75)

5.50 (3)

-

Day 10 – Pretreatment

–5 (1)

–2 (2)

<0.001

1 month – Pretreatment

–4 (1)

–1.50 (1.75)

<0.001

3 months – Pretreatment

–4 (1)

–1 (2)

<0.001

Age (years)

0.898

Sex
0.676
0.109

Injection level

0.102

Injection side
0.917

History of spinal surgery*
<0.001

NRS

Data are expressed as mean ± standard deviation, median (interquartile range), or n (%).
*Percentage based on spinal surgery variable.
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The logistic regression model was statistically
significant (p < 0.001) and fit the data (p = 0.987).
Treatment success was not associated with symptom
duration (p = 0.105), history of spinal surgery, or number
of previous spinal surgeries. However, an increase of 1 unit
in pretreatment NRS score was associated with 72% lower
odds of treatment success (p = 0.022). In addition, a 1-unit
increase in NRS score on posttreatment day 10 compared
to the pretreatment value was associated with 95% lower
odds of treatment success (p = 0.008).

A comparison of patients with and without a history
of spinal surgery in terms of age, symptom duration, and
NRS values is shown in Table 3.
There was no significant difference between patients with
and without a history of spinal surgery in terms of mean age,
median symptom duration, or pretreatment NRS values (p >
0.05). The reductions in NRS values at posttreatment 10 days,
1 month, and 3 months compared to pretreatment values
were significantly greater at all time points in patients with no
history of spinal surgery (p < 0.001 for all).

Table 2. Analysis of factors associated with treatment success.
Wald

OR (95% CI)

p value

2.64

0.83 (0.67–1.04)

0.105

0

0.46

0.28 (0.01–11.16)

0.499

1

2.83

0.01 (0–2.64)

0.093

Pretreatment

5.22

0.28 (0.10–0.84)

0.022

Posttreatment day 10 – pretreatment

7.04

0.05 (0.01–0.45)

0.008

Symptom duration
Previous spinal surgery (Ref cat: ≥2)

NRS

Model χ2=51.08, p < 0.001.
Hosmer–Lemeshow test: p = 0.987.
OR: Odds ratio, CI: Confidence interval, Ref cat: Reference category.

Table 3. Comparison of age, symptom duration, and NRS scores between patients with and without spinal surgery.
History of spinal surgery

P value

Yes (n = 21)

No (n = 27)

Age (years)

51.67 ± 13.04

51.44 ± 13.76

0.955

Symptom duration (months)

8 (18.50)

6 (7)

0.077

Pretreatment

6 (1.50)

6 (0)

0.292

Posttreatment day 10

4 (3.50)

2 (1)

-

Posttreatment month 1

4 (2.50)

2 (1)

-

Posttreatment month 3

5 (2.50)

2 (0)

-

Posttreatment day 10 – Pretreatment

–3 (3)

–5 (1)

<0.001

Posttreatment month 1 – Pretreatment

–2 (2)

–4 (1)

<0.001

Posttreatment month 3 – Pretreatment

–2 (2.50)

–4 (1)

<0.001

NRS

Data are expressed as mean ± standard deviation, median (interquartile range), or n (%).
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Figure 3. Relationship between treatment success and reduction in pain scores at 10 days, 1 month,
and 3 months after the treatment (*p < 0.001).

5. Discussion
In this study, combined TFESI and DRG-PRF therapy was
successful in 66.6% of patients with LRP related to LDH.
Patients with successful treatment outcomes at 3 months
showed a significantly greater reduction in NRS pain
scores 10 days after treatment. Although a history of spinal
surgery was less common among patients with treatment
success compared to patients with failed treatment, the
results of multivariate analysis showed that history of spinal
surgery did not significantly affect treatment success.
Administering TFESI to the ventral epidural region,
which is the site of pathological changes, is a targeted
and appropriate treatment option for herniation-related
LRP. A metaanalysis examining the efficacy of TFESI in
this patient group showed that it provides a moderate
analgesic benefit for 3 months [3]. Some studies
reported that DRG-PRF therapy resulted in significant
improvement in NRS and Oswestry disability index
(ODI) scores for 4 months in patients with chronic LRP
[4]. A study comparing the efficacy of DRG-PRF and
TFESI in the treatment of radicular pain associated with
LDH demonstrated improvements in visual analog scale
(VAS) and ODI scores for 3 months in both groups with
no statistically significant difference between them [10].
There are also studies in the literature examining whether
the combined use of TFESI and DRG-PRF increases
treatment success compared to TFESI alone. In a study
comparing the efficacy of combined TFESI and DRG-PRF
with TFESI alone, the TFESI and DRG-PRF group showed
significantly greater improvement in NRS and ODI
scores compared to the TFESI group for 3 months [2]. In
another study comparing the efficacy of combined TFESI
and DRG-PRF with TFESI alone, combined therapy was
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reported to result in significantly greater improvement in
VAS score compared to TFESI alone for the first 3 months,
but this effect disappeared at 4 months [5]. Therefore, the
patients in the present study were treated with TFESI and
DRG-PRF together in order to increase the effectiveness
of TFESI. Significant improvement in NRS scores for 3
months was observed in 66.6% of patients who underwent
combined TFESI and DRG-PRF therapy.
Ekedahl et al. reported in their study that younger age
(53–60 years) was a significant predictor of a favorable
response within 1 year after TFESI [6]. However, the
results of another study indicated that patients aged 60–69
years showed higher success after TFESI [11], while other
studies suggested that patient age has no effect on TFESI
treatment success [12]. In a study following patients for 6
months after DRG-PRF treatment, more successful results
were obtained in patients aged ≥55 years [9]. In another
study examining the efficacy of DRG-PRF in chronic LRP,
age >57 years was evaluated as a negative prognostic factor
for treatment success [13]. In the present study, there
was no significant association between patient age and
the 3-month results of combined TFESI and DRG-PRF
therapy. Studies including a wider range of age groups are
needed to elucidate the age factor. A study examining the
impact of sex on LRP prognosis concluded that women
had a 3.3-fold poorer prognosis than men within the first
year [14]. In another study of prognostic factors associated
with the success of DRG-PRF therapy, 72.3% of the patients
were women [9]. In the present study, women comprised
60.4% of the sample and no difference in sex distribution
was observed between patients with treatment success and
failure at 3 months after combined TFESI and DRG-PRF
therapy.

GAZİOĞLU TÜRKYILMAZ / Turk J Med Sci
Some authors have argued that shorter duration
of radicular pain symptoms has a favorable impact
on treatment success with TFESI [6]. In contrast, no
correlation between symptom duration and TFESI success
was observed in other studies [12]. However, there is
no previous study in the literature investigating the
relationship between DRG-PRF treatment for radicular
pain and the duration of symptoms. In the present study,
there was no difference in symptom duration between
patients with treatment success and failure. Further studies
with patient groups that have different symptom durations
are needed.
In a study examining the association between MRI
and fluoroscopic image findings and the success of TFESI
therapy, the procedure was performed most frequently at
L4-5 and second most frequently at L5-S1 [15]. In another
study to identify factors predicting the treatment success
of TFESI for LRP, the two most common procedure sites
were L5-S1 and the S1 foramen, respectively [12]. The
authors of both studies concluded that procedure level had
no effect on treatment success. In this study, procedures
were most commonly performed at L5-S1, followed by L45, and more frequently on the left side. Injection level and
side were not predictive of treatment success. Larger scale
studies are needed to obtain more accurate data.
Neuropathic pain after spinal surgery, called failed
back surgery syndrome (FBSS), is a common but
difficult-to-treat condition. Although the efficacy of
spinal cord stimulation in FBSS has been established in
the literature, epidural injections and DRG-PRF have
been recommended as a first-line treatment because they
are easy to perform and rarely cause complications [16].
Patients with FBSS who received epidural steroid injections
were shown to improve for the first month, after which the
effect of treatment decreased at 3- and 6-month follow-up
[17]. In another study, 2 out of 3 patients with FBSS who
underwent DRG-PRF had a fair to good improvement in
pain during a 6-month follow-up period, with 1 patient
reporting only short-term pain relief [18]. The results of a
study assessing the efficacy of DRG-PRF in patients with
LDH, spinal stenosis, and FBSS suggested that DRG-PRF
was ineffective in FBSS [8]. Although patients in the present
study who had undergone at least one spinal surgery were
more likely to have a treatment failure, history of spinal
surgery was not statistically associated with treatment
success. In order to provide clearer information on this
subject, prospective randomized controlled studies with
more patients and longer follow-ups are needed.
In a study to identify predictors of treatment success
with TFESI in LDH-induced radicular pain, the authors
reported that a greater reduction in NRS pain scores at 1 h
after the procedure was predictive of a favorable response
for 3 months after treatment, and they concluded that 1-h

NRS pain scores could be a useful marker for identifying
patients who will benefit from treatment [12]. In the
present study, a greater reduction in NRS scores 10 days
after combined TFESI and DRG-PRF therapy was able
to predict a favorable treatment response at 3 months.
Because day-10 NRS score is not a pretreatment factor, it
will not contribute to the prediction of treatment success
before the procedure. Nevertheless, predicting treatment
success after 10 days seems valuable for the patient and
the physician in terms of providing objective information
about the success of the procedure.
One of the limitations of this study is that diagnostic
selective nerve root block was not performed. In the
literature, one study comparing the effectiveness of TFESI
alone and combined with DRG-PRF involved preoperative
diagnostic TFESI, while no diagnostic test was performed
in another study [2,5]. Another limitation of this study
is the short-term follow-up and retrospective design.
Randomized controlled studies are needed to determine
whether this intervention is more effective in patients with
certain clinical characteristics.
6. Conclusion
This study showed that treatment success with combined
TFESI and DRG-PRF was not associated with patient age,
sex, symptom duration, procedure site, or history of spinal
surgery. However, the more favorable prognosis among
patients with a significant decrease in NRS score on day 10
is a finding that may shed light on the follow-up process.
The results of this study may serve as a guide for future
research.
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